Anti-allergy medicine EpiPen recall expands to US
A recall of the emergency anti-allergy medicine EpiPen is expanding to the U.S. and other markets in North America, Europe, Asia and South America because the allergy shots may not work.
The notice issued Friday by Mylan N.V. expands upon warnings made earlier this month after two reports of the device failing. The recall now covers 13 lots distributed from December 2015 through July 2016.
Mylan didn't immediately respond to a question about how many devices are affected by the recall.
The problems could be potentially life-threatening, although Mylan described the incidence of the defects as "extremely rare."
The EpiPen is used to treat allergic reactions to certain food and bug bites
The products can be replaced at no charge by calling 877-650-3494 or emailing customer.servicemylan.com.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Permanent injunction wanted for proposed Ascension Parish development
Residents praising NOPD response following weekend brawl on Bourbon Street
LSU caretakers respond to Mike the Tiger pouncing video
Some Metro Councilmemebers like new road tax plan better than last one
Asian carp a growing concern for fisherman
LSU Track star Aleia Hobbs happy she could represent her home state...
14-year-old CoCo Gauff wants to be the next star in pro tennis
Pete Jenkins reflects on 2017 season
Temeka Johnson basketball camp about more than the game
Saints looking to fill backfield void during Ingram's 4-game absence